Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

TNXP holding history

Tonix Pharmaceuticals Holding Corp. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TNXP overviewAll 13F holders of TNXPFull Q2 2026 holdings

Shares (Q2 2026)
15,241
Value
$194.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TNXP by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,241$194.5K<0.1%−2,029−11.7%ReducedHolders
Q1 202617,270$237.5K<0.1%−24,768−58.9%ReducedHolders
Q4 202542,038$656.6K<0.1%+26,363+168.2%AddedHolders
Q3 202515,675$378.7K<0.1%−3,253−17.2%ReducedHolders
Q2 202518,928$681.0K<0.1%+16,251+607.1%AddedHolders
Q1 20252,677$47.9K<0.1%−15,617−85.4%ReducedHolders
Q4 202418,294$6.03K<0.1%+18,045+7,247.0%AddedHolders
Q3 2024249$37<0.1%−2−0.8%ReducedHolders
Q2 2024251$176<0.1%−7,593−96.8%ReducedHolders
Q1 20247,844$1.46K<0.1%−118−1.5%ReducedHolders
Q4 20237,962$3.21K<0.1%−1,127−12.4%ReducedHolders
Q3 20239,089$4.95K<0.1%−1,372−13.1%ReducedHolders
Q2 202310,461$16.5K<0.1%−103,454−90.8%ReducedConverted for a 4-for-25 splitHolders
Q1 2023711,969$420.8K<0.1%+497,068+231.3%AddedHolders
Q4 2022214,901$83.8K<0.1%−718,671−77.0%ReducedHolders
Q3 2022933,572$498.0K<0.1%+46,856+5.3%AddedHolders
Q2 2022886,716$1.40M<0.1%+344,189+63.4%AddedHolders
Q1 2022542,527$125.0K<0.1%−334,834−38.2%ReducedHolders
Q4 2021877,361$313.0K<0.1%+614,912+234.3%AddedHolders
Q3 2021262,449$157.0K<0.1%−20,538−7.3%ReducedHolders
Q2 2021282,987$314.0K<0.1%+645+0.2%AddedHolders
Q1 2021282,342$361.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.